Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) shares were up 3.9% on Friday . The stock traded as high as $5.11 and last traded at $5.09, with a volume of 208,658 shares traded. The stock had previously closed at $4.90.

CLMT has been the subject of several recent research reports. Zacks Investment Research raised Calumet Specialty Products Partners, L.P from a “hold” rating to a “buy” rating and set a $5.25 price target for the company in a research report on Tuesday, April 19th. Wells Fargo & Co. cut Calumet Specialty Products Partners, L.P from an “outperform” rating to a “market perform” rating in a research report on Monday, April 18th. Cowen and Company reduced their price target on Calumet Specialty Products Partners, L.P from $23.00 to $10.00 and set a “market perform” rating for the company in a research report on Monday, April 18th. Ladenburg Thalmann cut Calumet Specialty Products Partners, L.P from a “buy” rating to a “neutral” rating and reduced their price target for the company from $27.00 to $11.00 in a research report on Friday, April 22nd. Finally, Janney Montgomery Scott cut Calumet Specialty Products Partners, L.P from a “buy” rating to a “neutral” rating and reduced their price target for the company from $17.00 to $8.00 in a research report on Monday, April 18th. Six analysts have rated the stock with a sell rating and nine have issued a hold rating to the stock. Calumet Specialty Products Partners, L.P currently has an average rating of “Hold” and an average target price of $10.71.

The firm has a 50-day moving average price of $4.72 and a 200 day moving average price of $7.84. The stock’s market cap is $391.02 million.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last issued its earnings results on Thursday, August 4th. The company reported ($1.89) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by $1.55. Equities research analysts expect that Calumet Specialty Products Partners, L.P will post ($1.77) EPS for the current year.

In other news, Director Stephen P. Mawer bought 11,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 18th. The stock was acquired at an average cost of $3.68 per share, with a total value of $40,480.00. Following the transaction, the director now directly owns 5,025 shares of the company’s stock, valued at approximately $18,492. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director James S. Carter bought 26,700 shares of the firm’s stock in a transaction that occurred on Tuesday, May 17th. The stock was purchased at an average cost of $3.72 per share, with a total value of $99,324.00. Following the completion of the transaction, the director now directly owns 66,341 shares in the company, valued at $246,788.52. The disclosure for this purchase can be found here.

An institutional investor recently bought a new position in Calumet Specialty Products Partners, L.P stock. Marshall Wace LLP purchased a new position in shares of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 209,614 shares of the company’s stock, valued at approximately $4,173,000. Marshall Wace LLP owned approximately 0.28% of Calumet Specialty Products Partners, L.P at the end of the most recent quarter.

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products. The Company operates through three segments. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.